• Products
    • Elisa Kits
    • CLIA Kit
    • PCR Kit
    • Secondary Antibody
    • Polyclonal Antibody
    • Monoclonal Antibody
  • Ordering
  • About Us
  • Contact us
MyBioSource Learning Center
  • Home
  • Research Surveys
  • Testing Procedures
  • ELISA Testing
    • Choosing the Right ELISA Kit
    • Elisa Assays in Pharmaceutical and Biotechnological Research
    • ELISA Sensitivity and Specificity
    • Best Practices for ELISA Sample Handling
    • ELISA Evolution
    • ELISA Assay Challenges
    • ELISA: Data Analysis and Interpretation
  • Blog
Select Page
Treatment Options For ALS Scarce; Medicines Focused On Suppressing Symptoms

Treatment Options For ALS Scarce; Medicines Focused On Suppressing Symptoms

by MyBiosource Editorial Team | Mar 1, 2017 | conditions

Table of Contents 1. Introduction 2. Lou Gehrig and the Connection to ALS 3. Stephen Hawking’s Rare Longevity with ALS 4. Variability and Complexity of ALS 5. Pathological Findings and the Need for More Research 6. Treatment and Quality of Life for ALS Patients...
Osteoporosis more about healthy foods and exercises than pills and supplements

Osteoporosis more about healthy foods and exercises than pills and supplements

by MyBiosource Editorial Team | Mar 1, 2017 | conditions

Table of Contents 1. Introduction: Osteoporosis and its impact on fractures 2. Factors that affect bone density and prevention of osteoporosis 3. The importance of protein in the diet and its impact on bone health 4. The risks of consuming elemental calcium and drugs...
Gene editing therapies could finally be the much expected cure for AIDS

Gene editing therapies could finally be the much expected cure for AIDS

by MyBiosource Editorial Team | Mar 1, 2017 | conditions

Table of Contents I. Introduction II. Complexity of Gene Replacement Techniques III. Progress in Gene Therapy Research and Gene Editing Technologies IV. Collaboration of Biogen and University of Pennsylvania for Gene Therapy Research V. Avellino Labs and Ulster...
Big changes needed in Alzheimer’s drug discovery approach

Big changes needed in Alzheimer’s drug discovery approach

by MyBiosource Editorial Team | Mar 1, 2017 | conditions

Table of Contents 1. Introduction: Eli Lilly’s failure in Alzheimer’s drug discovery 2. Focus of the solanezumab drug and its failure in clinical trials 3. Pathological findings in Alzheimer’s disease and the focus on targeting amyloid buildup 4....
Next Entries »

Recent Articles

ELISA Sensitivity and Specificity

ELISA Sensitivity and Specificity

June 5, 2025

Sensitivity reflects a test’s ability to correctly identify individuals with a disease or condition, while…

Read more

Sips Surge

April 8, 2025

Read more
ELISA Evolution

ELISA Evolution

August 6, 2024

Key Milestones 1941 – Introduction of Immunofluorescence In 1941, Albert H. Coons and his team were the first…

Read more
ELISA: Data Analysis and Interpretation

ELISA: Data Analysis and Interpretation

July 25, 2024

How to Analyze ELISA: 1. Run samples in duplicates or triplicates to ensure statistical accuracy. Average the readings…

Read more
ELISA: Qualitative vs. Quantitative

ELISA: Qualitative vs. Quantitative

July 24, 2024

ELISA plays a crucial role in various experiments, case studies, and surveys, where precise measurement and interpretation of…

Read more

Popular Posts

No posts found.

Categories

News97Uncategorized40outbreaks16conditions10Guest Posts4

Tags

ELISA5influenza4HIV4Chlamydia3Hepatitis B3colorectal cancer2Endometriosis2Monoclonal Antibody2Gonorrhoea2Hepatitis C2Influenza B2Zika Vaccine2

  • Facebook
  • X
  • RSS
Trending Kits (IL-6 elisa kit, INS elisa kit), CRP elisa kit, TDO2 elisa kit, TDO elisa kit)